Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,700 papers from all fields of science
Search
Sign In
Create Free Account
DOT1L gene
Known as:
KMT4
, DOT1L
, DOT1
Expand
This gene is involved in epigenetic control of gene expression.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (1)
DOT1L wt Allele
Gene Expression
Histone-Lysine N-Methyltransferase H3 Lysine-79 Specific, Human
Methylation
Protein methylation
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Recent progress in developing selective inhibitors of protein methyltransferases.
H. Kaniskan
,
Jian Jin
Current Opinion in Chemical Biology
2017
Corpus ID: 45890988
2017
2017
Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (SAM)-Dependent Methyltransferase Family.
Yulan Wang
,
Linjuan Li
,
+8 authors
M. Zheng
Journal of Medicinal Chemistry
2017
Corpus ID: 12948618
The disruptor of telomeric silencing 1-like (DOT1L) protein is a histone H3K79 methyltransferase that plays a key role in…
Expand
Review
2016
Review
2016
Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation
Jiajia Chen
,
Zhijun Miao
,
B. Xue
,
Y. Shan
,
Guobin Weng
,
Bairong Shen
Journal of Cancer
2016
Corpus ID: 4663939
Early diagnosis and surveillance for metastasis and recurrences are critical issues of urologic cancer. Deregulation of long non…
Expand
Review
2015
Review
2015
Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases.
Martin Chopra
,
S. Bohlander
Cancer Genetics
2015
Corpus ID: 25892719
2014
2014
Mitotic Accumulation of Dimethylated Lysine 79 of Histone H3 Is Important for Maintaining Genome Integrity During Mitosis in Human Cells
Brent J. Guppy
,
K. McManus
Genetics
2014
Corpus ID: 5571966
The loss of genome stability is an early event that drives the development and progression of virtually all tumor types. Recent…
Expand
2014
2014
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
S. Sarkaria
,
Matthew J. Christopher
,
J. Klco
,
T. Ley
Leukemia
2014
Corpus ID: 14589898
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
Review
2010
Review
2010
Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development
E. Barry
,
Gareth N. Corry
,
T. Rasmussen
Expert opinion on therapeutic targets
2010
Corpus ID: 13086152
Importance of the field: The establishment and maintenance of specialized chromatin is crucial for correct gene expression and…
Expand
Review
2010
Review
2010
Histone H 2 B ubiquitination and beyond Regulation of nucleosome stability , chromatin dynamics and the trans-histone H 3 methylation
M. Chandrasekharan
,
F. Huang
,
Zu-Wen Sun
2010
Corpus ID: 17056995
*Correspondence to: Zu-Wen Sun; Email: zuwen.sun@vanderbilt.edu Regulation of Set1-COMPASSmediated H3K4 methylation and Dot1…
Expand
2009
2009
Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation
F. V. Jacinto
,
E. Ballestar
,
M. Esteller
Oncogene
2009
Corpus ID: 24563725
Understanding the mechanisms that link changes in DNA methylation with histone modifications is particularly relevant in the case…
Expand
2003
2003
The Rtf 1 Component of the Paf 1 Transcriptional Elongation Complex Is Required for Ubiquitination of Histone H 2 B *
H. Ng
,
Sudhanshu Dole
,
K. Struhl
2003
Corpus ID: 33132170
In yeast cells, the Rtf1 and Paf1 components of the Paf1 transcriptional elongation complex are important for recruitment of Set1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE